theory clinical_46_3
imports Main

begin

typedecl entity
typedecl event

consts
  Inhibitors :: "entity ⇒ bool"
  PARP :: "entity ⇒ bool"
  DSBs :: "entity ⇒ bool"
  ReplicationAssociated :: "entity ⇒ bool"
  SSBreakRepair :: "entity ⇒ bool"
  HRR :: "entity ⇒ bool"
  NHEJ :: "entity ⇒ bool"
  Cause :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  Prevent :: "event ⇒ bool"
  Rely :: "event ⇒ bool"
  On :: "event ⇒ entity ⇒ bool"
  Repair :: "event ⇒ bool"
  DNA :: "event ⇒ bool"
  SyntheticLethality :: "entity ⇒ bool"
  GeneticEvents :: "entity ⇒ bool"
  CoOccurrence :: "entity ⇒ bool"
  CellDeath :: "entity ⇒ bool"
  Result :: "event ⇒ bool"
  Patients :: "entity ⇒ bool"
  Loss :: "entity ⇒ bool"
  PALB2 :: "entity ⇒ bool"
  Inhibition :: "entity ⇒ bool"
  PARP1 :: "entity ⇒ bool"
  Benefit :: "event ⇒ bool"
  Cells :: "entity ⇒ bool"
  Mechanism :: "event ⇒ bool"
  Damage :: "event ⇒ bool"

(* Explanation 1: PARP inhibitors cause replication‐associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA. *)
axiomatization where
  explanation_1: "∃x y z w e1 e2 e3 e4. Inhibitors x ∧ PARP x ∧ DSBs y ∧ ReplicationAssociated y ∧ SSBreakRepair z ∧ HRR w ∧ NHEJ w ∧ Cause e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Prevent e2 ∧ Agent e2 x ∧ Patient e2 z ∧ Rely e3 ∧ Agent e3 x ∧ On e3 w ∧ Repair e4 ∧ Agent e4 x ∧ DNA e4"

(* Explanation 2: Synthetic lethality is when co-occurrence of multiple genetic events results in cell death. *)
axiomatization where
  explanation_2: "∀x y z e. SyntheticLethality x ∧ GeneticEvents y ∧ CoOccurrence y ∧ CellDeath z ⟶ Result e ∧ Agent e y ∧ Patient e z"

theorem hypothesis:
  assumes asm: "Patients x ∧ Loss y ∧ PALB2 y ∧ Inhibition z ∧ PARP1 z ∧ SyntheticLethality w"
  (* Hypothesis: Patients with loss of PALB2 may benefit from PARP1 inhibition due to synthetic lethality causing cells to rely on a singular mechanism to repair cumulative damage to DNA. *)
  shows "∃x y z w e1 e2 e3 e4. Patients x ∧ Loss y ∧ PALB2 y ∧ Inhibition z ∧ PARP1 z ∧ SyntheticLethality w ∧ Benefit e1 ∧ Agent e1 x ∧ Patient e1 z ∧ Cause e2 ∧ Agent e2 w ∧ Patient e2 y ∧ Cells y ∧ Rely e3 ∧ Agent e3 y ∧ Mechanism e3 ∧ Repair e4 ∧ Agent e4 y ∧ Damage e4 ∧ DNA e4"
proof -
  (* From the premise, we have known information about patients, loss of PALB2, PARP1 inhibition, and synthetic lethality. *)
  from asm have "Patients x ∧ Loss y ∧ PALB2 y ∧ Inhibition z ∧ PARP1 z ∧ SyntheticLethality w" by blast
  (* We know from explanation 2 that synthetic lethality implies the co-occurrence of multiple genetic events and cell death. *)
  (* There is a logical relation Equivalent(E, And(F, G)), Equivalent(synthetic lethality, F & G) *)
  then have "CoOccurrence y ∧ CellDeath y" sledgehammer
  (* From the derived implications, we know that synthetic lethality implies cell death and co-occurrence of multiple genetic events. *)
  (* Implies(E, G) and Implies(E, F) *)
  then have "Result e2 ∧ Agent e2 y ∧ Patient e2 y" <ATP>
  (* We can infer that patients with loss of PALB2 may benefit from PARP1 inhibition due to synthetic lethality. *)
  (* This causes cells to rely on a singular mechanism to repair cumulative damage to DNA. *)
  then have "Benefit e1 ∧ Agent e1 x ∧ Patient e1 z ∧ Cause e2 ∧ Agent e2 w ∧ Patient e2 y ∧ Cells y ∧ Rely e3 ∧ Agent e3 y ∧ Mechanism e3 ∧ Repair e4 ∧ Agent e4 y ∧ Damage e4 ∧ DNA e4" <ATP>
  then show ?thesis <ATP>
qed

end
